Emergent BioSolutions Inc. (EBS)

NYQ – Real vaqt narxi. Valyuta: USD

4.49

+0.04 (1.01%)

Bozor ochiq: Aug 12, 2026, 2:48 PM EDT

4.46

+0.01 (0.22%)

Oldingi bozordan keyin: Aug 11, 2026, 7:57 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Emergent BioSolutions Inc. (EBS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Emergent BioSolutions Inc. (EBS)

EBS Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)

Emergent Biosolutions Q2 Earnings Call Highlights

Emergent BioSolutions Inc. (EBS) Q2 2026 Earnings Call Transcript

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

EBS Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Search stocks

Emergent BioSolutions Inc. (EBS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Emergent BioSolutions Inc. (EBS)

EBS Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)

Emergent Biosolutions Q2 Earnings Call Highlights

Emergent BioSolutions Inc. (EBS) Q2 2026 Earnings Call Transcript

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

EBS Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutions Reports Second Quarter 2026 Financial Results